-mediated inhibition of T cell p59 fyn is independent of cAMP. Am. J. Physiol. 277 (Cell Physiol. 46): C302-C309, 1999.-We recently observed that prostaglandin E 2 (PGE 2 )-mediated suppression of T cell functions could result from an attenuation of p59 fyn protein tyrosine kinase activity. The present study evaluated the effects of an adenylate cyclase agonist (forskolin) and antagonist (SQ-22536), as well as those of cAMP analogues (dibutyryl cAMP and 8-bromo-cAMP), on T cell p59 fyn kinase activity. The study allowed us to assess whether PGE 2 -mediated activation of adenylate cyclase by itself or the elevation in intracellular cAMP levels is an integral event in the modulation of anti-CD3-linked p59 fyn activation in T cells. The experiments were carried out with splenic T cells from male SpragueDawley rats. A 30-50% suppression in the autophosphorylation and the kinase activity of p59 fyn in T cells incubated with PGE 2 or forskolin was observed. Pretreatment of T cells with SQ-22536 prevented significant PGE 2 -mediated inhibition of T cell p59 fyn kinase activity. In contrast, no change in p59 fyn autophosphorylation and kinase activity in T cells treated with cAMP analogues was observed. These data suggest that PGE 2 -mediated suppression of p59 fyn autophosphorylation and kinase activity in T cells is dependent on the activation of adenylate cyclase and independent of the elevation in cAMP levels.
protein tyrosine kinase; src kinase; adenylate cyclase; phosphodiesterase; rat; prostaglandin E 2 PROSTAGLANDIN E 2 (PGE 2 ) has been shown to suppress T cell interleukin-2 (IL-2) production and proliferation in a number of inflammatory conditions including burn, trauma, and sepsis (2, 9, 15, 20, 21, 33, 39, 40) . In addition to inhibiting T cell proliferation, PGE 2 has been shown to suppress macrophage antigen-presenting ability (4, 22) . A decrease in T cell activation, either as a result of direct PGE 2 effect or due to a defect in antigen presentation, could contribute to an overall decrease in host resistance and an increased susceptibility to both opportunistic and nonopportunistic pathogens.
The activation of T cells is primarily induced via stimulation of the T cell receptor (TCR)-CD3 complex; it could be initiated in vitro via TCR ligation with lectins or with the antibody against CD3 (1, 8, 12, 13) . The earliest biochemical events after TCR ligation are increases in the activation of a number of protein tyrosine kinases including p59 fyn , p56 lck , and Zap-70 (19, 23, 28) . The activation of these kinases leads to phosphorylation of phospholipase C-␥ (PLC-␥), which hydrolyzes phosphatidylinositol 4,5-bisphosphate (PIP 2 ) into inositol 1,4,5-trisphosphate (IP 3 ) and 1,2-diacylglycerol (DAG) (8, 39) . Whereas IP 3 stimulates Ca 2ϩ release from the intracellular stores (7), DAG activates the protein tyrosine kinase C activity (35) . An increase in intracellular Ca 2ϩ concentration ([Ca 2ϩ ] i ) sustained for several hours precedes T cell activation and its subsequent proliferation activity (42) .
PGE 2 , acting on its receptors on T cells, stimulates adenylate cyclase to enhance the formation of cAMP (10, 11, 31, (38) (39) (40) . The elevation of cAMP levels in T cells has been implicated in the inhibition of T cell IL-2 production, IL-2 receptor (IL-2R) expression, and proliferation (2, 5, 9, 20, 34, 38, 40) . Our previous studies suggested that PGE 2 -mediated suppression of T cell proliferation could result from a disturbance in Ca 2ϩ signaling (16, 17) . Further, we have shown an inhibitory effect of PGE 2 on p59 fyn kinase activity, a component upstream to Ca 2ϩ signaling (18) . To investigate the mechanism of PGE 2 modulation of p59 fyn , the present study evaluated the effects of the incubation of T cells with cAMP analogues and with adenylate cyclase agonist forskolin on p59 fyn activation. Also, this study ascertained the effects of adenylate cyclase inhibitor SQ-22536 on p59 fyn kinase modulation by PGE 2 to determine whether adenylate cyclase activation is vital to PGE 2 -mediated modulation of p59 fyn in T cells.
MATERIALS AND METHODS
Reagents. PGE 2 , forskolin, and enolase were purchased from Sigma (St. Louis, MO). Dibutyryl-cAMP (DBcAMP), 8-bromo-cAMP (8-BrcAMP), IBMX, and SQ-22536 were purchased from Calbiochem-Novabiochem (La Jolla, CA). Monoclonal antibodies to p59 fyn (residues between amino acids 85 and 206 of human Fyn protein) were obtained from Santa Cruz Biotechnology (Santa Cruz, CA). Anti-rat CD3 antibodies were purchased from Pharmingen. [␥-32 P]ATP was obtained from DuPont NEN (Boston, MA). The specific activity of [␥-32 P]ATP is 3,000 Ci/mmol. Reagents for the SDS-PAGE were obtained from Bio-Rad (Richmond, CA). An Immobilon-P membrane (polyvinylidene difluoride) for the transfer of proteins was obtained from Millipore (Bedford, MA). Protein molecular weight markers and other reagents needed for the preparation of lysis buffer, wash buffer, and kinase buffer were obtained from Sigma. Nylon wool was obtained from Polysciences (Warrington, PA). Ficoll-Paque was purchased from Pharmacia (Uppsala, Sweden).
T cell preparation. Adults rats (ϳ250 g) were anesthetized (pentobarbital sodium; 65 mg/kg body wt) to remove the spleen and then were killed with a pentobarbital sodium overdose. Splenic T lymphocytes were isolated by previously described methods (16) (17) (18) . Briefly, spleens were gently ground to prepare a single cell suspension. Red blood cells and the dead cells from the suspension were removed by density gradient centrifugation with Ficoll-Paque. Splenocytes appearing at the interface of Ficoll-Paque and the medium were collected and added to nylon wool-packed columns. These columns were preequilibrated with Hanks' balanced salt solution (HBSS) supplemented with 10 mM HEPES, 5% FCS, and 50 mg/ml gentamicin. The columns containing cells were incubated at 37°C for 50-60 min. T cells were obtained by eluting the columns with 30-40 ml of HBSS at a flow rate of 1 drop/s. Flow cytometric analysis was carried out to assess the purity of the CD3-positive cells by using anti-CD3 antibodies. It was found that 90-95% of the cells were CD3 positive (data not shown).
Stimulation of T cells and lysate preparation. Rat splenic T cells were stimulated with soluble anti-CD3 antibodies (1 µg/ml) for 180 s at 37°C. The stimulation was stopped by cell solubilization in a phosphorylation lysis buffer (PLB). PLB was prepared by mixing 50 mM HEPES, 150 mM NaCl, 1 mM EDTA, 100 mM NaF, 1 mM MgCl 2 , 10 mM Na 4 P 2 O 7 , 200 µM Na 3 VO 4 , 0.5% Triton X-100, and 10% glycerol on ice for 45-50 min. Lysates were centrifuged at 10,000 rpm for 5 min at 4°C.
In some experiments, T cells were incubated with PGE 2 (10 µM), forskolin (10 µM), or cAMP analogues (doses in the figure legends) for 2 h before stimulation with anti-CD3. These experiments allowed us to assess the effects of PGE 2 , forskolin, or cAMP analogues on anti-CD3-linked p59 fyn autophosphorylation and kinase activity in T cells. For the measurements of SQ-22536 or IBMX effects, T cells were incubated with SQ-22536 or IBMX for 30 min and then with PGE 2 or cAMP analogues, respectively, for an additional 2 h.
Immunoprecipitation. Lysates were incubated with monoclonal antibodies to p59 fyn protein for 1 h, and then the mixture was incubated with protein G-Sepharose beads for another 2 h (18). These incubations were carried out at 4°C. The precipitates were washed three times in PLB without added glycerol.
In vitro kinase assay. This assay was performed by a previously described method (18) . After the final wash, immune complexes were collected and washed two times with in vitro kinase buffer (50 mM Tris · HCl, pH 7.4, 10 mM MnCl 2 , 0.1% Triton X-100). After these washes, kinase assays were performed by incubating immune complexes first with 5 µg/ml acid-treated enolase and then for 30 min with 10 µCi [␥-32 P]ATP. These incubations were carried out at room temperature (28°C). Samples were analyzed by SDS-PAGE, and the proteins were transferred to the Immobilon-P membrane. Phosphoproteins were analyzed by autoradiography, and the intensities of the bands were assessed by densitometry.
Reprobing the membranes. Membranes were reprobed for equal protein loading after stripping the antibodies. For stripping, membranes were incubated with stripping buffer (65 mM Tris · HCl, pH 6.8, 100 mM 2-mercaptoethanol, 2% SDS). The membranes were saturated with blocking buffer (10 mM Tris, 150 mM NaCl, 0.05% Tween 20 supplemented with 10% BSA) for 1 h at room temperature or for 16-20 h at 4°C; this was followed by an incubation with anti-p59 fyn antibody (1:200 dilution) at 4°C. The membranes were washed three times with wash buffer (10 mM Tris, 150 mM NaCl, 0.05% Tween 20) and were incubated with a secondary antibody conjugated with horseradish peroxidase (1:3,000 dilution) and then washed. After the final wash, membranes were probed with enhanced chemiluminescence dye and proteins were autoradiographed.
Assessment of T cell cAMP levels. Splenic T cells were incubated with various reagents for 2 h, and the intracellular accumulation of cAMP was measured with an enzyme immunoassay kit from Cayman Chemical (Ann Arbor, MI).
RESULTS
Effect of stimulation or blockade of adenylate cyclase on p59 fyn . The effects of PGE 2 on p59 fyn autophosphorylation and its phosphorylation of enolase are shown in Fig. 1A . There was no detectable phosphorylation of p59 fyn or enolase by p59 fyn in T cells without their stimulation with anti-CD3 antibodies. Stimulation of T cells with anti-CD3 resulted in increased autophosphorylation of p59 fyn as well as increases in its kinase activity. The autophosphorylation of p59 fyn induced by anti-CD3 was significantly suppressed in T cells incubated with PGE 2 compared with T cells incubated without PGE 2 . Likewise, the phosphorylation of enolase by p59 fyn in PGE 2 -treated T cells was significantly lower than that observed in untreated T cells. Densitometric analyses of 10 or more similar experiments suggested a 30-50% inhibition of p59 fyn autophosphorylation and its kinase activity in T cells treated with PGE 2 compared with the untreated T cells (Fig. 1, C  and D) . Figure 1B shows the equal-protein-loading controls for blots shown in Fig. 1A .
As shown in Fig. 2, A and B, treatment with SQ-22536 prevented PGE 2 -caused inhibition of p59 fyn autophosphorylation as well as kinase activity in T cells stimulated with anti-CD3. This SQ-22536 effect was found to be dose dependent. Blots from three or more experiments performed with various doses of SQ-22536 were analyzed by densitometry, and the pooled data from these experiments are shown in Fig. 2 , C and D. SQ-22536 alone had no effect on the anti-CD3-linked autophosphorylation and kinase activity of p59 fyn . The doses of SQ-22536 used in the present study had no effects on cell viability, as tested by the trypan exclusion test. To further ascertain the role of adenylate cyclase on p59 fyn , we assessed the anti-CD3-linked autophosphorylation and kinase activity of p59 fyn in T cells incubated with or without forskolin. Forskolin has been used widely to directly upregulate adenylate cyclase activity . As shown in Fig. 3 , the stimulation of adenylate cyclase with forskolin significantly inhibited the autophosphorylation and kinase activity of p59 fyn . These data suggested that the activation of adenylate cyclase was critical for PGE 2 -mediated inhibition of p59 fyn in T cells.
Effect of cAMP analogues on p59 fyn . T cells were incubated with various concentrations of DBcAMP before their stimulation with anti-CD3, and then p59 fyn autophosphorylation and kinase activity were assessed. Surprisingly, there was no difference in p59 fyn autophosphorylation and its ability to phosphorylate enolase whether or not T cells were treated with DBcAMP (Fig. 4A) . We also assessed p59 fyn autophosphorylation and kinase activity in T cells after their incubation with 8-BrcAMP. 8-BrcAMP also failed to affect autophosphorylation and kinase activity (Fig.  5A) . The lack of effect of cAMP analogues on p59 fyn could be due to an insufficient increase in intracellular cAMP levels resulting from the treatment of cells with (Table 1) show that all three agents, PGE 2 , forskolin, and the cAMP analogues, increased cellular cAMP. Prior treatments of T cells with SQ-22536 significantly inhibited PGE 2 -induced elevation of intracellular levels of cAMP. The potential role of intracellular cAMP on p59 fyn was further examined by inhibiting T cell phosphodiesterases with IBMX. In these experiments, cAMP analogues (DBcAMP and 8-BrcAMP) were added to T cells in the presence of phosphodiesterase inhibitor IBMX. The results from these experiments are shown in Fig. 5 , A and C. In the cAMP analogue-treated T cells, the presumed further increase in cAMP after phosphodiesterase inhibition did not have any effect on the activation of p59 fyn . The above results suggested that although there was an increase in intracellular levels of cAMP after the treatment of T cells with PGE 2 , forskolin, or cAMP analogues (DBcAMP or 8-BrcAMP), such increases in cAMP levels did not contribute to the PGE 2 -related inhibition of p59 fyn phosphorylation and its kinase activity.
DISCUSSION
Whereas some studies have suggested that PGE 2 -mediated alteration in the transcriptional regulation of IL-2 and IL-2R results in attenuated T cell proliferation (2, 14, 33, 36) , others have shown an impairment in the TCR-related early signaling events contributing to disturbed T cell functions (11, 15, 25, (30) (31) (32) (33) 39) . In our previous studies (16-18), we found that PGE 2 -mediated inhibition of p59 fyn kinase activity could be a component of the early signaling events that impaired the downstream signaling, including the elevation in [Ca 2ϩ ] i and the transcriptional regulation of IL-2. The present study evaluated a cross talk between the anti-CD3-and PGE 2 -mediated signaling pathways. Our data demonstrated that PGE 2 -mediated suppression of p59 fyn is dependent on the activation of adenylate cyclase. However, the elevation of the intracellular cAMP level appeared to have no effect on the anti-CD3-mediated activation of p59 fyn , suggesting that the block http://ajpcell.physiology.org/ in p59 fyn activation was dependent on the activation of adenylate cyclase but independent of cAMP.
The accumulation of intracellular cAMP after T cell stimulation with PGE 2 is a common finding in a number of previous studies (10, 24, 25, 29, 38, 40) . The correlation between elevated levels of cAMP and suppression of Ca 2ϩ signaling and IL-2 transcription in T cells has been generally taken to indicate cAMP mediation of T cell dysfunction (2, 6, 15, 32, 34, 39, 41, 44) . Our study has shown that although cAMP modulation did occur because of PGE 2 action, cAMP itself was not required for the PGE 2 -mediated suppression of p59 fyn . The inability of cAMP to modify p59 fyn signaling in T cells is also supported by experiments in which intracellular cAMP hydrolysis was prevented by means of phosphodiesterase inhibition.
That cAMP might be involved in the suppression of TCR-mediated signaling events was demonstrated primarily by studies using cAMP-elevating agents, cholera toxin, and forskolin (3, 5, 10, 31, 39, 40) . Both cholera toxin and forskolin act on G s protein to stimulate adenylate cyclase, leading to the accumulation of cAMP (3, 10, 25, 27) . cAMP is known to stimulate protein kinase A (PKA) in a number of cell types including T cells (2, 5, 6, 26, 32, 43) . Furthermore, PKA has been shown to inhibit the PLC-␥-mediated hydrolysis of PIP 2 to IP 3 and DAG (6, 24, 31, 32, 37, 38) . An inhibition of PLC-␥, PIP 2 hydrolysis, and the IP 3 -related elevation in [Ca 2ϩ ] i has been observed after adenylate cyclase activation of T cells with forskolin (24, (30) (31) (32) 44) . Thus a direct activation of adenylate cyclase via forskolin and cholera toxin leading to cAMP accumulation could inhibit Ca 2ϩ signaling in T cells and thereby prevent their activation and the expression of T cell functions. However, other studies have shown that although cholera toxin-mediated activation of adenylate cyclase, subsequent to G s ␣ activation, could effect both an increase in cAMP and a decrease in the Ca 2ϩ signal in T cells, the decrease in Ca 2ϩ signaling with increased accumulation of cellular cAMP could not be shown (3, 24, 25, 27, 29, 31) . The intracellular Ca 2ϩ signaling decrease could result not only from G s ␣ activation but also from an interference with PLC-␥ activation caused by p59 fyn inhibition. The latter possibility is indicated by the dependence of PLC-␥ activation on p59 fyn activity (8, 13, 28) . Our previous studies had shown that PGE 2 -mediated inhibition of p59 fyn is correlated with downregulation of the Ca 2ϩ signal (18) . However, we do not know whether the downregulation of the Ca 2ϩ signal was due exclusively to p59 fyn inhibition or due additionally to an inhibitory effect of PGE 2 -mediated G s ␣ activation and cAMP accumulation on the Ca 2ϩ signal. Because we have found that PGE 2 downregulates p59 fyn in a cAMP-independent manner, we postulate that the Ca 2ϩ signal downregulation by PGE 2 is partly through p59 fyn inhibition and partly due to accumulation of cAMP.
The precise mechanism for p59 fyn suppression has remained unclear. A speculative mechanism for p59 fyn inhibition could be that PGE 2 -mediated activation of the G protein and adenylate cyclase couples to some adapter protein, which could lead to a downregulation of p59 fyn tyrosine kinase and/or an upregulation of protein tyrosine phosphatases. An alternative possibility could be that, as for cholera toxin, PGE 2 activation of the G protein and adenylate cyclase modifies the TCR-homodimer () chain (1, 8) located upstream of p59 fyn , as has been shown by Haack et al. (25) . A modulation in the -chain could alter p59 fyn autophosphorylation and kinase activity.
